MedPath

安徽艾立德制药有限公司

Ownership
-
Established
2019-10-15
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Alendronate Sodium Tablets

Product Name
阿仑膦酸钠片
Approval Number
国药准字H20254214
Approval Date
May 20, 2025
NMPA

Agomelatine Tablets

Product Name
阿戈美拉汀片
Approval Number
国药准字H20253818
Approval Date
Apr 8, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.